Accellient Partners is a fully integrated and dedicated team of drug development experts with broad drug development, regulatory and scientific experience. Our team designs, implements and manages all product development needs for biotech co's. Accellient's development model leverages know-how, technology and business experience to; Minimize program risks and lower costs; Accelerate development timelines via tailored development plans; Achieve targeted milestones to improve return on investment; and Assist in the capital raising process.We develop and manage programs from late discovery through IND submission and Phase 2. We also continue to support the manufacturing requirements and nonclinical development needs of projects through the complex registration process. Our approach enables business leaders and investors to fully assess all risk factors and their impact on success to support major investment and infrastructure decisions.Accellient partners with clients in all markets. We provide core technical drug development expertise and an extensive network of expert affiliates, KOL's and proven service providers that complement your discovery, development and management team. We are currently filing electronic INDs quarterly and have significant experience working with all divisions of the FDA. Accellient offers an efficient and cost effective approach and strives to be the biopharmaceutical and investment industries' virtual drug development partner of choice.